BioCentury
ARTICLE | Clinical News

Diovan valsartan cardiovascular data

September 12, 2005 7:00 AM UTC

Data from the Val-HeFT trial in 5,010 heart failure patients showed that beneficial effects of Diovan in reducing mortality and morbidity were not significantly different in the presence of renal dysf...